Horst Wähling

Statistics

Publications

Citations

247

H-Index

Active since

2007

Affiliations

Medivir (Sweden)(Current)

Uppsala University

Janssen (Belgium)

Horst Wähling is an author at Medivir (Sweden) specializing in drug discovery, antiviral structure-activity relationships, and antiviral pharmacology.

Publications per year

2007–2017

Publications

Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350

Pierre Raboisson, Herman de Kock, Åsa Rosenquist et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 136 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: Use of cyclopentane and cyclopentene P2-motifs

Marcus Bäck, Per-Ola Johansson, Fredrik Wångsell et al. · Bioorganic & Medicinal Chemistry · 2007 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: Exploration of P2 quinazoline substituents

Magnus Nilsson, Anna Karin Belfrage, Stefan B. Lindström et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 24 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Discovery of 4′-azido-2′-deoxy-2′-C-methyl cytidine and prodrugs thereof: A potent inhibitor of Hepatitis C virus replication

Magnus Nilsson, Genadiy Kalayanov, Anna Winqvist et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 20 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Discovery of β-d-2′-deoxy-2′-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication

Pedro Pinho, Genadiy Kalayanov, Hans Westerlind et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 20 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 6